参考文献/References:
[1] LI M Y,YANG Y L,LIU L,et al.Effects of social support,hope and resilience on quality of life among Chinese bladder cancer patients:a cross-sectional study[J/OL].[2020-09-01].https://hqlo.biomedcentral.com/articles/10.1186/s12955-016-0481-z.
[2] 陈晓芳,陈万青,周薇薇,等.2013年中国膀胱癌发病和死亡流行状况分析[J].中国肿瘤,2018,27(2):81-85.
[3] 马娥,杨明莹,王剑松,等.膀胱癌尿流改道腹壁造口患者生活质量及影响因素研究进展[J].护理学报,2017,24(2):21-23.
[4] WELDRING T,SMITH S M.Patient-reported outcomes(PROs)and Patient-reported outcome measures(PROMs)[J].Health Serv Insights,2013(6): 61-68.
[5] 刘砚燕,陈如男,姚静静,等.患者报告结局的国内外研究进展[J].现代预防医学,2013,40(12):2268-2271,2279.
[6] U.S.Department of Health and Human Services FDA Center for Drug Evaluation and Research,U.S.Department of Health and Human Services FDA Center for Biologics Evaluation and Research,U.S.Department of Health and Human Services FDA Center for Devices and Radiological Health.Guidance for industry:patient-reported outcome measures:use in medical product development to support labeling claims:draft guidance[J/OL].[2020-09-06].https://hqlo.biomedcentral.com/articles/10.1186/1477-7525-4-79.
[7] FISCELLA K,RANSOM S,JEAN -PIERRE P,et al.Patient -reported outcome measures suitable to assessment of patient navigation[J].Cancer,2011,117(15 Suppl):3603-3617.
[8] BONOMI A E,CELLA D F,HAHN E A,et al.Multilingual translation of the functional assessment of cancer therapy(FACT)quality of life measurement system[J].Qual Life Res,1996,5(3):309-320.
[9] CELLA D F,TULSKY D S,GRAY G,et al.The fimctional assessment of cancer therapy scaler development and validation of the general measure[J].J Clin Oncol,1993,11(3):570-579.
[10]万崇华,孟琼,汤学良,等.癌症患者生命质量测定量表FACT-G中文版评介[J].实用肿瘤杂志,2006,21(1):77-80.
[11]WEBSTER K,CELLA D,YOST K.The functional assessment of chronic illness therapy(FACIT)Measurement System:properties,applications,and interpretation[J/OL].[2020-09-10].https://hqlo.biomedcentral.com/articles/10.1186/1477-7525-1-79.
[12]朱锐.膀胱全切原位尿流改道术后并发症分析及生活质量评估[D].昆明:昆明医科大学,2017.
[13]DEGBOE A,IVANESCU C,ROHAY J M,et al.Validity and performance of the functional assessment of cancer therapy-bladder(FACT-Bl)among advanced urothelial cancer patients[J].Support Care Cancer,2019,27(11):4189-4198.
[14]ZAHRAN M H,SHEIR K,ZIDAN E M,et al.Validation of the arabic version of the functional assessment of cancer therapy-bladder questionnaire in Egyptian patients with bladder cancer.[J].Arab J Urol,2017,15(2):110-114.
[15]HINOTSU A,NIIMI M,AKAZA H,MIYANAGA N,et al.Development of Japanese version of QOL questionnaire for bladder and prostate cancer patients using FACT-Bl and P:pilot study[J].Gan To Kagaku Ryoho,1999,26(5):657-666.
[16]COOKSON M S,DUTTA S C,CHANG S S,et al.Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder:development and validation of a new disease specific questionnaire[J].J Urol,2003,170(5):1926-1930.
[17]ANDERSON C B,FEURER I D,LARGE M C,et al.Psychometric characteristics of a condition-specific,health-related quality-of-life survey:the FACT-vanderbilt cystectomy index[J].Urology,2012,80(1):77-83.
[18]MYONG K,SEUNG-JUNE O,CHEOL K,et al.Psychometric validation study of the Korean version of the functional assessment of cancer therapy-vanderbilt cystectomy index[J/OL].[2020-09-10].https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0190570.
[19]KARIN S,ANNA-KARIN L,JENNY W,et al.Patient-reported outcome after radical cystectomy:translation and psychometric validation of the Swedish version of the functional assessment of cancer therapy scale vanderbilt cystectomy index[J].Scand J Urol,2016,50(5):374-379.
[20]AARONSON N K,AHMEDZAI S,BERGMAN B,et al.The European Organization for Research and Treatment of Cancer QLQ-C30:a quality-of-life instrument for use in international clinical trials in oncology[J].J Natl Cancer Inst,1993,85(5):365-376.
[21]杨铮,宣辉,万崇华,等.膀胱癌患者生命质量影响因素的多重回归分析:QLQ-C30与QLQ-BLM30量表应用[J].实用肿瘤杂志,2015,30(1):29-32.
[22]万崇华,陈明清,张灿珍,等.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355.
[23]BOTTEMAN M F,PASHOS C L,HAUSERR S,et al.Quality of life aspects of bladder cancer:a review of the literature[J].Qual Life Res.2003,12(6):675-688.
[24]NORMANN C O,OPHEIM R,ANDREASSEN B K,et al.Health-related quality-of-life after radical cystectomy among Norwegian men and women compared to the general population[J].Scand J Urol,2020,54(3):181-187.
[25]刘建平.膀胱癌患者生命质量量表的研制与考评[D].昆明:昆明医学院,2010.
[26]PARK J S,SHIN D W,KIM T H,et al.Development and validation of the Korean Version of the European Organization for research and treatment of cancer quality of life questionnaire for patients with non-muscle invasive bladder cancer:EORTC QLQ-NMIBC24[J].Cancer Res Treat,2018,50(1):40-49.
[27]BLAZEBY J M,HALL E,AARONSON N K,et al.Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer[J].Eur Urol,2014,66(6):1148-1156.
[28]杨金玲.EORTC QLQ量表在浅表性膀胱癌患者生存质量研究中的应用[D].济南:山东大学,2008.
[29]MOGENSEN K,CHRISTENSEN K B,VRANG M L,et al.Hospitalization for transurethral bladder resection reduces quality of life in Danish patients with non-muscle-invasive bladder tumour[J].Scand J Urol,2016,50(3):170-174.
[30]GILBERT S M,DUNN R L,HOLLENBECK B K,et al.Development and validation of the bladder cancer index:a comprehensive,disease specific measure of health related quality of life in patients with localized bladder cancer[J].J Urol,2010,183(5):1764-1769.
[31]GILBERT S M,WOOD D P,DUNN R L,et al.Measuring health-related quality of life outcomes in bladder cancer patients using the bladder cancer index(BCI)[J].Cancer,2010,109(9):1756-1762.
[32]MONCRIEF T J,BALAJI P,LINDGREN B B,et al.Comparative evaluation of bladder-specific health-related quality of life instruments for bladder cancer[J].Urology,2017(108):76-81.
[33]SIRACUSANO S,NIERO M,LONARDI C,et al.Development of a questionnaire specifically for patients with ileal orthotopic neobladder(IONB)[J/OL].[2020-09-05].https://hqlo.biomedcentral.com/articles/10.1186/s12955-014-0135-y.
[34]PERLIS N,KRAHN M D,BOEHME K E,et al.The bladder utility symptom scale:a novel patient reported outcome instrument for bladder cancer[J].J Urol,2018,200(2):283-291.
[35]MASON S J,CATTO J W,DOWNING A,et al.Evaluating patient-reported outcome measures(PROMs)for bladder cancer:a systematic review using the consensus-based standards for the selection of health measurement instruments(COSMIN)checklist[J].BJU Int,2018,122(5):760-773.
相似文献/References:
[1]邓睿华,许小明,徐丽君.血液透析患者报告结局评估工具的研究进展[J].解放军护理杂志,2022,39(02):76.[doi:10.3969/j.issn.1008-9993.2022.02.019]
[2]王金燕,杨瑒,朱凌曦,等.基于患者报告结局的乳腺癌患者社会功能的特征分析研究[J].解放军护理杂志,2022,39(07):21.[doi:10.3969/j.issn.2097-1826.2022.07.006]
WANG Jinyan,YANG Yang,ZHU Lingxi,et al.Characteristics of Social Functioning Among Breast Cancer Patients: An Analysis Based on Patient-Reported Outcomes[J].Nursing Journal Of Chinese People’s Laberation Army,2022,39(06):21.[doi:10.3969/j.issn.2097-1826.2022.07.006]
[3]房培,谭兰惠,李佳,等.癌症患儿自我报告结局评估工具的研究进展[J].解放军护理杂志,2023,40(06):73.[doi:10.3969/j.issn.2097-1826.2023.06.018]
[4]汪红姣,王颖,吴梅利洋,等.膀胱癌患者尿流改道术式决策冲突现状及影响因素分析[J].解放军护理杂志,2023,40(09):60.[doi:10.3969/j.issn.2097-1826.2023.09.015]
WANG Hongjiao,WANG Ying,WU Meiliyang,et al.Status Quo of Decision Conflicts Among Bladder Cancer Patients with Urinary Diversion and Its Influencing Factors[J].Nursing Journal Of Chinese People’s Laberation Army,2023,40(06):60.[doi:10.3969/j.issn.2097-1826.2023.09.015]
[5]彭蕾,张佳怡,李家熠,等.基于患者报告结局的美军慢性疼痛评估研究进展[J].解放军护理杂志,2023,40(11):93.[doi:10.3969/j.issn.2097-1826.2023.11.022]
[6]程文瑜,高凯霞,王静,等.膀胱癌术后患者经济毒性水平多中心调查及其机制研究[J].解放军护理杂志,2023,40(12):42.[doi:10.3969/j.issn.2097-1826.2023.12.011]
Cheng Wenyu,Gao Kaixia,Wang Jing,et al.A Multi-centered Survey and Research into the Mechanism on Postoperative Financial Toxicity of Bladder Cancer Patients[J].Nursing Journal Of Chinese People’s Laberation Army,2023,40(06):42.[doi:10.3969/j.issn.2097-1826.2023.12.011]